← Every company
Compass Inc Patents
What Compass Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
COMP on carbonthat →Filings on file
52
Granted
13
Still pending
39
Filed under
17 names
52 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| PSILOCYBIN COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING THE SAMEA61K 9/4858, A61K 31/661, A61K 31/675, A61P 25/24, A61K 9/08, A61K 9/2013, A61K 9/2054, A61K 9/2059, A61K 9/4833, A61K 9/4866, A61K 47/12, A61K 47/14, A61K 47/36Filed as Compass Pathfinder Limited2026-06-09David Philip ELDER | pending |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2026-04-28Derek John LONDESBROUGH | pending |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2026-04-28Derek John LONDESBROUGH | pending |
| METHOD AND SYSTEM FOR ENABLING LOCATION FINDING AND MESSAGE COMMUNICATION BETWEEN A PLURALITY OF DIGITAL COMPASS DEVICESG01S 5/0072, G01S 19/36, G01S 19/14, G01S 19/37, G01S 19/51Filed as Crowd Compass Inc.2026-04-22Christopher James Stanley Dimoff | pending |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2026-03-26Derek John LONDESBROUGH | pending |
| METHODS FOR TREATING ANXIETY DISORDERS, HEADACHE DISORDERS, AND EATING DISORDERS WITH PSILOCYBINA61K 31/675, A61P 19/04, A61P 9/10, A61P 25/20, A61P 25/28, A61P 25/30, A61P 1/16, A61P 25/22, A61P 17/00, A61P 25/04, A61P 37/08, A61P 1/12, A61P 3/10, A61P 9/12, A61P 25/18, A61P 25/24, A61P 1/00, A61P 11/00, A61P 25/00, A61P 25/08, A61P 25/16, A61P 29/00, A61P 1/04, A61P 25/06, A61K 9/0053, A61K 9/20, A61K 9/48, A61K 31/4045, A61K 31/661, A61K 45/06, C07B2200/13, C07F 9/5728Filed as Compass Pathfinder Limited2026-03-17Derek John LONDESBROUGH | 12751960 |
| MULTISPECIFIC BINDING CONSTRUCTS TARGETING PD-1 AND VEGF AND USES THEREOFFiled as COMPASS THERAPEUTICS, LLC.2026-01-06BING GONG | pending |
| FURNITURE ASSEMBLY AND CONSTRUCTION METHODA47B 13/08, A47B 13/021, A47B2230/0074, B25H 1/00Filed as Compass Rose Toolworks, LLC2025-12-10Rex Krueger | pending |
| MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND USES THEREOFA61P 35/00, C07K 16/2818, C07K 16/2827, A61P 35/02, A61K2039/505, A61K2039/507, C07K2317/21, C07K2317/24, C07K2317/31, C07K2317/33, C07K2317/35, C07K2317/526, C07K2317/565, C07K2317/71, C07K2317/73, C07K2317/76, C07K2317/92, C07K2317/94Filed as Compass Therapeutics, LLC2025-11-24Bing GONG | pending |
| NOVEL PROGNOSTIC BIOMARKERS IN PATIENTS WITH CANCERFiled as COMPASS THERAPEUTICS LLC2025-11-04KRIS SACHSENMEIER | pending |
| MULTISPECIFIC BINDING CONSTRUCTS TARGETING PD-1 AND VEGF AND USES THEREOFFiled as Compass Therapeutics, LLC2025-10-28Bing GONG | pending |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2025-08-11Derek John LONDESBROUGH | 12662498 |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2025-08-11Derek John LONDESBROUGH | 12668605 |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2025-08-11Derek John LONDESBROUGH | pending |
| METHODS FOR TREATING ANXIETY DISORDERS, HEADACHE DISORDERS, AND EATING DISORDERS WITH PSILOCYBINA61K 31/675, A61P 19/04, A61P 9/10, A61P 25/20, A61P 25/28, A61P 25/30, A61P 1/16, A61P 25/22, A61P 17/00, A61P 25/04, A61P 37/08, A61P 1/12, A61P 3/10, A61P 9/12, A61P 25/18, A61P 25/24, A61P 1/00, A61P 11/00, A61P 25/00, A61P 25/08, A61P 25/16, A61P 29/00, A61P 1/04, A61P 25/06, A61K 9/0053, A61K 9/20, A61K 9/48, A61K 31/4045, A61K 31/661, A61K 45/06, C07B2200/13, C07F 9/5728Filed as Compass Pathfinder Limited2025-08-11Derek John LONDESBROUGH | 12611418 |
| SUBCUTANEOUS FORMULATIONS COMPRISING PSILOCYBIN DERIVATIVESA61K 9/0019, A61K 31/4045, A61P 25/18, A61K 47/02, A61K 47/26Filed as Compass Pathfinder Limited2025-07-18John Richard MORPHY | pending |
| METHOD AND APPARATUS FOR DISPERSING OILB05B 5/005, B05B 5/025, B05B 5/043, B05B 5/082, B05B 5/10, B05D 1/04, B21D 37/08, B21D 37/18, F16N 5/02, B05B 14/30, B05B 1/044, B05B 5/03, B05B 5/084, B05B 5/14, B05B 12/122, B21D 22/201Filed as Compass Systems & Sales, LLC2025-06-30Roger Speece | pending |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2025-06-12Derek John LONDESBROUGH | 12643917 |
| METHODS OF TREATING NEUROCOGNITIVE DISORDERS, CHRONIC PAIN AND REDUCING INFLAMMATIONA61K 31/675, A61P 19/04, A61P 9/10, A61P 25/20, A61P 25/28, A61P 25/30, A61P 1/16, A61P 25/22, A61P 17/00, A61P 25/04, A61P 37/08, A61P 1/12, A61P 3/10, A61P 9/12, A61P 25/18, A61P 25/24, A61P 1/00, A61P 11/00, A61P 25/00, A61P 25/08, A61P 25/16, A61P 29/00, A61P 1/04, A61P 25/06, A61K 9/0053, A61K 9/20, A61K 9/48, A61K 31/4045, A61K 31/661, A61K 45/06, C07B2200/13, C07F 9/5728Filed as Compass Pathfinder Limited2025-06-11Derek John LONDESBROUGH | pending |
| SALT FORMS OF BIS(3-(2-(DIMETHYLAMINO)ETHYL)-1 H-INDOL-4-YL) 3,3'¬OXYDIPROPIONATEA61K 31/4045, C07D 209/16, A61P 25/00, C07B2200/13, C07C 55/06, C07C 55/10, C07C 55/14, C07C 57/15, C07C 59/19, C07C 59/305, C07C 255/61Filed as Compass Pathfinder Limited2025-05-16John Richard MORPHY | pending |
| SCALABLE METHODS OF MANUFACTURING PSILOCYBINC07F 9/5728, C07B 49/00, C07B2200/13Filed as Compass Pathfinder Limited2025-04-10Ronnie Maxwell LAWRENCE | pending |
| COMBINATION OF ANTIBODIES TARGETING DLL4/VEGF AND CD137 AGONISTS OR ANTI-PD1/ANTI-PD-L1 ANTIBODIES FOR THE TREATMENT OF CANCERFiled as COMPASS THERAPEUTICS, INC.2025-04-02DIANA ALBU | pending |
| CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOFC07K 16/2878, A61P 35/00, A61K 39/001111, A61K 39/001117, A61K2039/507, C07K2317/565, C07K2317/75, C07K2317/92Filed as Compass Therapeutics LLC2025-03-18Ugur Eskiocak | pending |
| COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTIONA61K 9/0019, A61K 40/42, A61K 40/32, A61K 40/31, A61K 40/11, A61K 39/0008, A61K 39/39, A61K2039/505, C07K 14/70535, C07K 14/70539, C07K2317/622Filed as Compass Point Group, LLC2025-03-18Colleen M. O'CONNOR | pending |
| SALT FORMS OF BIS(3-(2-(DIMETHYLAMINO)ETHYL)-1 H-INDOL-4-YL) 3,3'-OXYDIPROPIONATEFiled as Compass Pathfinder Limited2025-02-21John Richard MORPHY | pending |
| MULTISPECIFIC BINDING CONSTRUCTS TARGETING PD-1 AND VEGF AND USES THEREOFFiled as Compass Therapeutics LLC2025-02-18Bing GONG | pending |
| SINK DRAIN PLUG SCREENFiled as COMPASS MANUFACTURING INTERNATIONAL, LLC2025-01-10DeChang Li | D1125483 |
| Multispecific Binding Constructs Targeting PD-1 and VEGF and Uses ThereofFiled as Compass Therapeutics LLC2025-01-07Bing GONG | pending |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2024-12-20Derek John LONDESBROUGH | 12459965 |
| WORKBENCHFiled as Compass Rose Toolworks, LLC2024-12-11Rex Krueger | pending |
| Novel Prognostic Biomarkers in Patients With CancerFiled as Compass Therapeutics LLC2024-11-05Kris SACHSENMEIER | pending |
| DOVETAIL SQUAREFiled as Compass Rose Toolworks, LLC2024-10-02Rex Krueger | D1108932 |
| Systems and Methods for Controlling Predictive Modeling Processes on a Mobile DeviceG06F 30/20, G06F2111/08, G06Q 40/06Filed as Compass Point Retirement Planning, Inc.2024-08-28Michael James LaBrie | pending |
| 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl OLIGOMERIC DERIVATIVESA61K 31/4045, C07D 209/16, A61P 25/22, A61P 25/18, A61P 25/24, A61P 25/00, A61P 25/06Filed as Compass Pathfinder Limited2024-08-23John Richard MORPHY | pending |
| 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVESA61K 31/4045, C07D 209/16, C07F 7/0812, A61P 25/22, A61P 25/18, A61P 25/24, A61P 25/00, A61P 25/06, A61K 31/403, A61K 31/4155, A61K 31/454, A61K 31/675, A61K 31/685, A61K 31/695, C07D 401/12, C07D 403/12, C07D 417/12, C07F 9/062, C07F 9/5728Filed as Compass Pathfinder Limited2024-08-23John Richard MORPHY | pending |
| FAUCET WITH CASCADING RINSE MODULEE03C 1/0405, B05B 1/044, E03C 1/16, E03C 1/0404, E03C 1/048Filed as COMPASS MANUFACTURING INTERNATIONAL, LLC2024-07-25Ken Sapp | pending |
| SUBCUTANEOUS FORMULATIONS COMPRISING PSILOCYBIN DERIVATIVESFiled as Compass Pathfinder Limited2024-07-19John Richard MORPHY | pending |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2024-07-09Derek John LONDESBROUGH | 12312375 |
| METHOD AND SYSTEM FOR ENABLING LOCATION FINDING AND MESSAGE COMMUNICATION BETWEEN A PLURALITY OF DIGITAL COMPASS DEVICESG01S 5/0072, G01S 19/36, G01S 19/14, G01S 19/37, G01S 19/51Filed as Crowd Compass Inc.2024-06-27Christopher James Stanley Dimoff | 12631765 |
| SYSTEM AND COMPUTER-IMPLEMENTED METHOD FOR AUTOMATING ACTIVATION OF DISPLAY OF INFORMATIONG06F 16/9035, G06F 16/909, G06F 16/958Filed as THE CLOUD AND COMPASS LTD2024-06-17DAN DOUGLAS | 12271427 |
| COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTIONA61K 9/0019, A61K 39/39, A61K 40/42, A61K 40/32, A61K 40/31, A61K 40/11, A61K 39/0008, A61K2039/505, C07K 14/70535, C07K 14/70539, C07K2317/622Filed as Compass Point Group, LLC2024-06-13Colleen M. O'CONNOR | pending |
| PSILOCYBIN AND AN ADJUNCTIVE SEROTONIN REUPTAKE INHIBITOR FOR USE IN THE TREATMENT OF TREAMENT- RESISTANT DEPRESSIONA61K 31/675, A61P 25/24, A61K 9/0053, A61K 9/4866, A61K 31/135, A61K 31/138, A61K 31/343, A61K 31/4525, A61K 31/495, A61K 31/496, A61K2300/00Filed as Compass Pathfinder Limited2024-06-10Hans Åke ERIKSSON | pending |
| ADJUSTABLE PERSONNEL STAND AND METHOD OF USEB66F 11/04, B66F2700/09Filed as Compass Systems & Sales, LLC2024-06-03Roger Edward Speece | pending |
| Transparent Flexible CircuitsH05K 1/0274, H05K 1/0393, G02B 6/4259, H05K 1/0281, H05K 1/09, H05K 3/386, H05K2201/0154, H05K2201/0355Filed as Xiamen Compass Technology Co., Ltd.2024-05-17Kelvin Po Leung Pun | pending |
| SALT FORMS OF BIS(3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-YL) 3,3'-OXYDIPROPIONATEFiled as Compass Pathfinder Limited2024-05-17John Richard MORPHY | pending |
| TREATMENT OF TREATMENT RESISTANT DEPRESSION WITH PSILOCYBINFiled as COMPASS PATHFINDER LIMITED2024-04-23Trevor Anthony MILL | pending |
| SCALABLE METHODS OF MANUFACTURING PSILOCYBINFiled as Compass Pathfinder Limited2024-04-12Ronnie Maxwell LAWRENCE | pending |
| METHOD AND SYSTEM FOR PROVIDING NETWORKED DIGITAL COMPASS DEVICESFiled as Crowd Compass Inc.2024-04-05Christopher James Stanley Dimoff | pending |
| Antibodies and Immunotherapy Targeting Immune Modulatory Receptors and Methods of Using the SameFiled as Compass Therapeutics, Inc.2024-04-04Diana ALBU | pending |
| MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND USES THEREOFA61P 35/00, C07K 16/2818, C07K 16/2827, A61P 35/02, A61K2039/505, A61K2039/507, C07K2317/21, C07K2317/24, C07K2317/31, C07K2317/33, C07K2317/35, C07K2317/526, C07K2317/565, C07K2317/71, C07K2317/73, C07K2317/76, C07K2317/92, C07K2317/94Filed as Compass Therapeutics, LLC2024-03-19Bing GONG | 12503511 |
| CERVICOTHORACIC MATA61B 50/20, A61B 46/23, A61B 50/33, A61B 90/08, A61B2090/0813Filed as Surgical Compass LLC2024-03-04Shauna Regina Fearon | 12648825 |
| PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEA61K 31/675, C07F 9/5728, A61P 25/28, A61P 25/24, A61P 25/00, A61K 9/0053, A61K 9/1652, A61K 9/2054, A61K 9/4866, A61K 31/661, A61K 47/36, A61K 47/38, C07B 63/00, C07B2200/13, C07D 209/16Filed as Compass Pathfinder Limited2024-02-05Derek John LONDESBROUGH | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on COMP
Company overviewEverything on COMP in one place, with the price.SEC filingsWhat COMP's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat COMP's own officers and directors buy and sell.Who owns itEvery manager reporting a position in COMP.Funds holding itWhich funds and ETFs hold COMP, and how big a bet.LobbyingWhat COMP spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on COMP's account, and who they worked for.Federal contractsWhat federal agencies pay COMP.Workplace safetyWhat OSHA found at COMP's sites.